Arie Barlev

Arie Barlev is a seasoned pharmaceutical industry professional with over 15 years of experience, currently serving as the Vice President and Head of Global Value, Access and Outcomes at Atara Biotherapeutics, Inc., based in the San Francisco Bay Area.1

Professional Experience

At Atara Biotherapeutics, Barlev leads a team of health economists and outcomes researchers. His role involves providing strategic guidance and analytical support to advance the development and commercialization of novel cell therapies for patients with serious diseases.1

Prior to his current position, Barlev held several notable roles:

• Senior Director and Head of Health Economics and Outcomes Research Group at Medivation (later acquired by Pfizer) from August 2015 to March 2017.1
• Various positions at Amgen, including Director and Senior Manager, from July 2005 to July 2015.1
• Senior Scientist at Covance from 2004 to 2005.1

Academic Involvement

Alongside his industry roles, Barlev served as an Adjunct Professor at California State University Northridge from January 2009 to July 2015.1

Core Competencies

Barlev's expertise includes:

• Synthesizing complex healthcare data for decision-making
• Developing innovative solutions to improve healthcare delivery and outcomes
• Utilizing real-world data (RWD), real-world evidence (RWE), and patient-reported outcomes (PRO)
• Demonstrating product value to stakeholders such as payers, providers, regulators, and patients
• Promoting evidence-based policies balancing healthcare cost and quality
• Effectively communicating insights to both technical and non-technical audiences1

Arie Barlev's extensive experience and leadership in the pharmaceutical industry, particularly in health economics and outcomes research, position him as a key figure in advancing novel therapies and improving patient outcomes.